Quick Guide to Recent Changes We’ve Made to G2’s Reports
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The changes affect the Office of Product Evaluation and Quality’s Office of In Vitro Diagnostics and Radiological Health.
By the end of this month, G2 Intelligence’s website will have a new look and feel, plus simplified site navigation.
Recent report shows physician revenues, compensation, and productivity rose in the first quarter of 2022, but so did subsidies and expenses.
The IVDR will bring around 80 percent of in vitro diagnostic medical devices under the control of so-called Notified Bodies.
While the much-delayed IVDR will take effect at the end of the month, it will be rolled out gradually.
According to a recent survey of product security experts, despite many saying their companies are ready for hacks, data show otherwise.
Agency warns the public to be on the lookout as counterfeit at-home OTC COVID-19 diagnostic tests appear on the US market.
New report shows a fair portion of prior authorization and physician reimbursement request denials actually met Medicare coverage rules.
In last week’s announced enforcement actions involving the healthcare industry, two defendants were sentenced, one was convicted, and two others were charged in various fraud-related schemes.
Case is part of a larger coordinated enforcement action targeting COVID-19-related fraud spanning seven judicial districts.